Skip to main
NEOG
NEOG logo

Neogen (NEOG) Stock Forecast & Price Target

Neogen (NEOG) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Neogen Corporation is expected to see a rebound in revenue growth driven by an underlying portfolio that indicates potential for strong performance in the food safety sector, despite a challenging comparison in the previous year. Management's focus on integrating the supply chain and improving gross profit margins is anticipated to enhance financial metrics such as adjusted EBITDA. Additionally, the rising awareness of health and safety among consumers, combined with an increase in food allergies over recent decades, suggests a favorable market environment for Neogen's products and services.

Bears say

Neogen Corporation's stock faces a negative outlook primarily due to significant operational challenges, including integration issues and customer attrition stemming from a troubled transition following its acquisition of 3M's Food Safety division. The company has missed multiple financial targets as manufacturing bottlenecks have resulted in backlog issues, jeopardizing sales and customer trust. Additionally, Neogen's valuation is notably low compared to its peers, sitting at a discount due to lingering integration risks, which further compounds investor concerns regarding the company's future performance.

Neogen (NEOG) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Neogen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Neogen (NEOG) Forecast

Analysts have given Neogen (NEOG) a Buy based on their latest research and market trends.

According to 5 analysts, Neogen (NEOG) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $39, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $39, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Neogen (NEOG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.